Patents by Inventor Helen Ulrika Sjögren

Helen Ulrika Sjögren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE LIQUID GONADOTROPIN FORMULATION
    Publication number: 20230372447
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Application
    Filed: April 21, 2023
    Publication date: November 23, 2023
    Applicant: Ferring B.V.
    Inventors: Helen Ulrika Sjögren, Charlott Hojer-Pedersen
  • Stable liquid gonadotropin formulation
    Patent number: 11666635
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: June 6, 2023
    Assignee: Ferring B.V.
    Inventors: Helen Ulrika Sjögren, Charlotte Hojer-Pedersen
  • STABLE LIQUID GONADOTROPIN FORMULATION
    Publication number: 20210236600
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Application
    Filed: September 14, 2020
    Publication date: August 5, 2021
    Inventors: Helen Ulrika Sjögren, Charlotte Hojer-Pedersen
  • Stable liquid gonadotropin formulation
    Patent number: 10792334
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: October 6, 2020
    Assignee: Ferring B.V.
    Inventors: Helen Ulrika Sjögren, Charlotte Højer-Pedersen
  • STABLE LIQUID GONADOTROPIN FORMULATION
    Publication number: 20190060409
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 28, 2019
    Inventors: Helen Ulrika Sjögren, Charlotte Højer-Pedersen
  • Stabilization of FSH
    Patent number: 8993732
    Abstract: The present invention, pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: March 31, 2015
    Assignee: Ferring B.V.
    Inventors: Helen Ulrika Sjögren, Heidi Louise Bagger
  • STABILIZATION OF FSH
    Publication number: 20130210727
    Abstract: The present invention, pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts.
    Type: Application
    Filed: July 28, 2011
    Publication date: August 15, 2013
    Applicant: FERRING B.V.
    Inventors: Helen Ulrika Sjögren, Heidi Louise Bagger